Trials / Completed
CompletedNCT05702723
Building Resiliency Among Caregivers of Curvivors and Metavivors
Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this research study is to assess the feasibility and participants' satisfaction of the Stress Management and Resiliency - Relaxation Response Resiliency Program (SMART-3RP) and compare this treatment with SMART-3RP versus referral to a group-based, online support group to see which is better for improving resilience and decreasing distress of participants with cancer and their caregivers. The name of the study intervention involved in this study is: Smart-3RP (virtual, mind-body group treatment program).
Detailed description
This pilot, randomized controlled trial assesses the feasibility, acceptability, and efficacy of the Stress Management and Resiliency - Relaxation Response Resiliency Program (SMART-3RP) for improving resiliency and decreasing distress among caregivers and cancer survivors compared to enhanced usual care. Participants will be randomly assigned into one of the study groups: Smart-3RP versus referral to a group-based, online support group. Randomization means that a participant is placed into a group by chance. Participation in this study is expected to last about 180 days. It is expected about 96 people made up of 48 patients and 48 caregivers will take part in this research study. The National Institutes of Health (NIH) is supporting this research by providing funding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Smart-3RP | 9 sessions of mind-body group treatment program via Zoom platform. |
| BEHAVIORAL | Enhanced Usual Care | 14-week group-based, online support group through CancerCare.org. |
Timeline
- Start date
- 2023-06-10
- Primary completion
- 2024-10-01
- Completion
- 2025-01-01
- First posted
- 2023-01-27
- Last updated
- 2026-04-13
- Results posted
- 2026-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05702723. Inclusion in this directory is not an endorsement.